Vizille, France

Eve Duchemin-Pelletier

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eve Duchemin-Pelletier: Innovator in Muscle Regeneration

Introduction

Eve Duchemin-Pelletier is a prominent inventor based in Vizille, France. She has made significant contributions to the field of muscle regeneration through her innovative research and patents. With a total of three patents to her name, her work focuses on enhancing skeletal muscle health and performance.

Latest Patents

Eve's latest patents include groundbreaking inventions such as ALK5 inhibitors as skeletal muscle hypertrophy inducers. This invention relates to the use of ALK5 inhibitors to promote skeletal muscle regeneration, prevent muscle atrophy, and treat conditions resulting in muscle tissue loss or weakness. Additionally, she has developed LSD1 inhibitors as skeletal muscle hypertrophy inducers, which serve similar purposes in enhancing muscle mass, strength, and performance.

Career Highlights

Eve Duchemin-Pelletier is currently associated with Cytoo, a company known for its innovative approaches in the life sciences sector. Her work at Cytoo has allowed her to explore and develop her ideas further, contributing to advancements in muscle health.

Collaborations

Eve collaborates with talented individuals such as Joris Michaud and Pauline Poydenot, who share her passion for innovation and research in muscle regeneration.

Conclusion

Eve Duchemin-Pelletier stands out as a leading inventor in the field of muscle regeneration, with her patents paving the way for new treatments and enhancements in muscle health. Her contributions are vital to advancing our understanding and capabilities in this important area of research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…